School navigation

Board of Trustees

Patrick Mahaffy ’85

Patrick Mahaffy is currently President and CEO of Clovis Oncology Inc., a company he cofounded in May 2009.  Clovis is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anticancer agents in the United States, Europe and additional international markets.  It targets its development programs for the treatment of specific subsets of cancer populations, and seeks to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients that are most likely to benefit from their use. Clovis is currently developing three product candidates for which it holds global marketing rights: CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine, which is in a pivotal study in a specific patient population for the treatment of metastatic pancreatic cancer; CO-1686, an orally available, small molecule epidermal growth factor receptor, or EGFR, covalent inhibitor that is currently in preclinical development for the treatment of non-small cell lung cancer, or NSCLC, in patients with activating EGFR mutations, including the initial activating mutations, as well as the primary resistance mutation, T790M; and CO-338, an orally available, small molecule poly (ADP-ribose) polymerase, or PARP, inhibitor being developed for various solid tumors that is currently in a Phase I clinical trial.  Clovis is headquartered in Boulder, Colorado, and has additional offices in San Francisco and Cambridge, England.
 
Mr. Mahaffy has significant biotechnology and pharmaceutical executive management experience. He was the founder of Pharmion Corporation and served as its President and CEO from its inception through its acquisition eight years later. Under Mr. Mahaffy’s leadership, Pharmion successfully acquired, developed and gained approval for several oncology products in the U.S. and Europe and achieved significant revenues and sustained growth from those products until its acquisition by Celgene Corporation for $2.9 billion in March 2008.
 
Patrick Mahaffy graduated from Lewis & Clark with a degree in International Relations in 1985. He also participated in the France Overseas Study Program while a student here. His studies continued at the Columbia School of International Affairs where he received an M.A.
 
Patrick “Pat” Mahaffy has two children and resides in Boulder, Colorado.

Board of Trustees

Contact Us

  • David Ellis
    Vice President, Secretary, and General Counsel
    Phone 503-768-7691
    Fax 503-768-7688
    E-mail
    dgellis@lclark.edu

    Tina Blackwell
    Executive Assistant to the President
    Phone 503-768-7680
    E-mail
    clb@lclark.edu

    Bonny Benton
    Paralegal/Executive Assistant to Vice President, Secretary & General Counsel
    Phone 503-768-7689
    E-mail 
    bbenton@lclark.edu

    Office fax 503-768-7688